Skip to main content
Fig. 4 | European Journal of Hybrid Imaging

Fig. 4

From: Preliminary clinical assessment of dynamic carbon-11 methionine positron-emission tomography/computed tomography for the diagnosis of the pathologies in patients with musculoskeletal lesions: a prospective study

Fig. 4

A 78-year-old woman with metastatic soft tissue tumour from gastric cancer in the left thigh. Dynamic positron-emission tomography/computed tomography (PET/CT) (ad) images are shown. In all dynamic phases (ad), the soft tissue tumour is avid for methionine (MET). The inhomogeneous and intense MET accumulation in soft tissue tumours is identifiable from the dynamic first phase (SUVmax: dynamic first phase (a), 7.15; dynamic second phase (b), 8.09; dynamic third phase, 9.03; dynamic fourth phase (c), 10.28; dynamic fifth phase, 10.94; dynamic sixth phase (d), 11.34). The accumulation gradually becomes more intense in most parts of the tumour during the dynamic phases (ad). The time-SUVmax curve (e) shows a high level in SUVmax at the dynamic first phase and a continuous increase during the dynamic phases

Back to article page